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Objectives: The aim of this study was to benchmark the proposal forms used by a
sample of Italian hospitals to inform the budget process for the adoption of new
technology to understand the relationship with the guidelines provided by the Health
Technology Assessment (HTA) literature.
Methods: A literature review was first undertaken to identify the frameworks developed to
support decision making regarding new technology at a hospital level. A checklist of
criteria drawn up according to five main perspectives (technology, patient, organization,
economics, and level of evidence) has been formalized to review and compare the
collected proposal forms.
Results: The “technology” perspective appears to have been broadly covered. The
“patient” perspective has focused to clinical issues and partially neglects other dimensions
such as patient satisfaction and potential adverse events. The “organization” dimension
has paid little attention to change management. The “economics” dimension has been
broadly covered, even though a sensitivity analysis has not been considered. The “level of
evidence” that is required for submitting the proposal form is little.
Conclusions: The proposal forms used to inform the budget process regarding the
adoption of new technology are accountable for a limited set of dimensions from among
those proposed in literature. Further research is required to understand how to render
technology assessment multidimensional, multidisciplinary, evidence-based, and
accountable at a hospital level.
Keywords: Health technology assessment, Priority setting, Budget, Hospitals, Healthcare
technology
The increasing pace of development of innovative health-
care technologies forces both regulators and providers to be
responsible for the portfolio of technologies that has to be
promoted and adopted for the delivery of health services.
Many economists and policy analysts consider innovation in
technology—along with weak cost-containment measures—
to be a major driver in rising healthcare costs (15). The Health
Technology Assessment (HTA) discipline has received in-
creasing attention over the past few years as an instrument
that can support decision making at each level in healthcare.
The literature pertaining to HTA has recently started to
investigate the applicability of HTA guidelines at a hospital
level. The problem of selecting new technology is not a nov-
elty for hospitals—in fact, the budget process copes with this
502
https://doi.org/10.1017/S0266462308080665
Downloaded from https:/www.cambridge.org/core. Open University Library, on 09 Feb 2017 at 14:12:21, subject to the Cambridge Core terms of use, available at https:/www.cambridge.org/core/terms.
Budgeting and health technology assessment
issue every year—but what is new is the increasing commit-
ment to the improvement of the rationality and fairness of
this priority setting exercise (13). In fact, the resources de-
voted to adopting or maintaining technologies are more and
more limited at a hospital level and the demand is increas-
ing more and more. From this point of view, hospitals are
required to improve both accountability and responsibility in
the budget process (4), in particular concerning the adoption
of new (expensive) technology.
The rising interest of hospitals in HTA can be explained
as the commitment to renew the present practices of assessing
and selecting new technology, taking into account some of
the guidelines developed within the HTA discipline. A recent
study has claimed that approximately 66 percent of Danish
hospitals apply an HTA-based framework on a regular basis
to support decision making (7). A recent article, published
by one of the most well-known Italian financial newspaper,
has claimed that approximately 83 percent of Italian hospitals
apply the HTA discipline for priority setting (3). In particular,
the 2006–2008 Italian National Healthcare Plan remarks that
HTA is the natural basis for improving the rationality and
accountability of technology adoption and management in
the national healthcare system at every level.
This study aims at providing preliminary evidence about
the integration of the budget process and HTA guidelines at a
hospital level. The extent of integration is reviewed in terms
of accountability of data collecting. The proposal forms used
to give information to the budget process about the adoption
of new technology have been reviewed to identify which
dimensions are accountable at a hospital level.
The review of the proposal forms to suggest the adop-
tion of a technology to the budget committee provides a
useful picture of the extent to which the concepts of rational-
ity, multidimensionality and evidence, which are typical of
HTA, have penetrated the budget process. Although HTA at a
hospital level and HTA for governmental resource allocation
decisions have different purposes, they should share the same
principles. In an ideal world, HTA at a hospital level should
cover all the domains of HTA, but this is not realistic in the
real world. The review of the proposal forms shed light on
which data are required to inform decision making regarding
the adoption of new technology at a hospital level.
METHODS
The authors used a multiple case study methodology (17) for
the empirical research. The in-depth analysis of a single case
allows the peculiarities and the determinants to be understood
at an early stage of knowledge, while a cross-case compar-
ison is appropriate when attempting to externally validate
the findings from a single case study. The research design
is based on two sequential steps. First, a literature review
about priority setting at a hospital level, aimed at supporting
the interviews was carried out. Second, an analysis of the
selected cases was conducted. In the following, both steps
are described briefly.
Electronic Literature Search
The authors carried out an electronic literature search from
January 1990 onward covering PubMed, Medline, and Cilea
to collect the relevant contributions about priority setting at
a hospital level. The references of the selected contributions
were also reviewed. The priority setting exercise was limited
to the choice of which portfolio of equipment or medical de-
vices would be adopted by a hospital. The authors excluded
the other healthcare technologies (such as medicine) because
they were particularly interested in understanding the de-
gree of integration between the budget process and the HTA
guidelines. To be included, a contribution had to describe, in
whole or part, a method or criteria to select an equipment or
a medical device. The identified contributions were reviewed
for relevancy by the three authors separately, on the basis
of the title and abstract. If at least one reviewer identified
a contribution as being potentially relevant, the full paper
was obtained. The collected papers were then reviewed and
selected if all the authors considered them to meet the selec-
tion criteria. A brief textual description was written for each
priority setting method, in particular concerning the various
analysis dimensions and the required proof of evidence.
Multiple Case Study Analysis
The empirical exercise involved four Italian hospitals (see
Table 1 for details; the real names have been made anony-
mous for confidentiality reasons). These hospitals were se-
lected because of the interest they have paid in HTA over the
past few years and because of the possibility of having access
to confidential information. Moreover, over the past 2 years,
the demand for new technology in the hospitals in the sam-
ple has more than doubled compared with the availability of
financial resources. The analysis was carried out as follows:
• At the beginning of each case, a relationship was established
with the Health Director of the hospital. He was briefed about
the research project and the authors asked to be introduced to two
Clinical Department Heads, to the Head of Clinical Engineering
and to the Head of the Financial Department;
• The authors personally interviewed the selected figures; they
undertook a semistructured interview for each respondent (each
interview on average lasted 1 hour) to gather the information
required;
• The proposal forms used to collect the data required to inform
the selection of new technology were collected and reviewed in
comparison with the dimensions that emerged during the litera-
ture review;
• A preliminary within-case analysis was performed; the purpose
was to consider each case study as a separate one to understand to
what extent each hospital is accountable regarding the selection
of new technology; the findings from each case were checked
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Table 1. Details of Hospitals Included in the Case Study Sample
A B C D
Number of beds 1.300 1.200 1.100 447
Ownership (private vs. public) Public Public Public Public
Location (city vs. local hospital) City City City City
Teaching Status (teaching vs. NON teaching) Teaching Non Non Non
Number of physicians (circa) 1.000 800 1.000 450
Number of clinical engineers (with an MSc) 1 2 1 2
Number of operating theatres 33 38 35 6
Number of intensive care units 63 60 65 58
Total yearly budget for investments (thousands of euros) 4.000 6.000 3.500 3.000
with the interviewees during two meetings to identify and correct
potential misunderstandings.
• Finally, a cross-case analysis was undertaken to compare the
patterns that emerged in each case study to obtain a wider un-
derstanding and explanation.
FRAMEWORK
The research about priority setting at a hospital level was
mainly focused on the healthcare services portfolio that
health agencies or hospitals should deliver to maximize the
health gains for a given population against scarce resources.
Numerous studies have investigated hospital performances
in terms of efficiency, assuming the hospitals as a black
box. Other studies have carried out health technology assess-
ment (HTA) exercises about specific healthcare technologies,
while neglecting to investigate the relationship between the
incremental cost-effectiveness ratio and the peculiarities of
each hospital. Other studies have investigated how a specific
set of variables may or may not influence the adoption of a
specific healthcare technology by hospitals. Despite that, the
number of studies that argue a reference framework for tech-
nology adoption at a hospital level is limited. In particular,
the authors decided to select seven contributions according
to the inclusion protocol described in the Methods section.
Uphoff and Krane (16) conducted a pioneering study
in this field. They proposed a reference flowchart for capi-
tal planning and technology assessment at a hospital level.
They also proposed a checklist of twelve questions that cover
different analysis perspectives, such as: linkage to strategy,
health and social impacts on patients, safety, risks, and costs.
Ehlers et al. (7) proposed the Danish mini-HTA as a tool to
conciliate the HTA philosophy and the practice of technology
assessment. The assessment exercise is based on twenty-six
questions, many of which are similar to the ones proposed by
Uphoff and Krane (16). The questions are grouped into four
main assessment perspectives: technology, patient, organi-
zation and the financial aspects. Briones et al. (2) described
the results of the Spanish GANT project (Guide for Acquisi-
tion of New Technologies) which identifies five assessment
perspectives: technology, health problem, evidence on effi-
cacy, effectiveness and safety, organization, and economics.
Azzone et al. (1) applied capital budgeting techniques to
give information on the adoption of an innovative Linear Ac-
celerator for oncology treatment in a Italian hospital. The
authors identify four main perspectives against which the
impacts of the adoption of a healthcare technology should
be reviewed: increase of revenues, containment of costs, im-
provement of flexibility and creation of strategic options.
Sloane et al. (14) investigate the possibility of using the An-
alytical Hierarchical Process (AHP) to aid the selection of
devices for cardiovascular diseases at a hospital level. After
three interactions with the decision makers, they identified
four main assessment perspectives: technological features,
clinical factors, safety, and costs. Farrar et al. (9) applied
discrete choice modeling to priority setting to select the op-
timal combination of clinical service developments within
a given budget. The model is based on cost-utility compar-
isons. Preference are measured by asking the consultants to
make choices between different scenarios involving different
levels of a limited set of benefits. The authors identified five
main benefits: (i) health gain for patients;(ii) contribution to
education, training and research; (iii) contribution to profes-
sional development; (iv) strategy area (national versus local);
(v) level of evidence of clinical evidence. A specific value
for each level of benefit is proposed. The preferences give
information on the estimation of the regression equation to
give weights to the benefits. Finally, information on the costs
is combined with the benefit scores to estimate a cost per
unit of benefit ratio for each of the proposed developments.
Lettieri and Masella (11) argued that hospital-based HTA
should consider two dimensions: (i) potential value, and (ii)
degree of applicability. The potential value of a healthcare
technology is related to social gains, economic gains, and
knowledge development. The degree of applicability is mea-
sured considering five areas: (i) economics, (ii) organization,
(iii) technology, (iv) resources, and (v) demand.
The identified contributions propose different reference
frameworks to give information on technology assessment
at a hospital level. The criteria have been reviewed, com-
pared and systematized in a reference framework based on
five main perspectives (i.e., technology, patient, organiza-
tion, economics, evidence). The proposal forms collected
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from the hospitals were reviewed considering the reference
framework. The set of criteria for each perspective is shown
in detail in Table 2.
RESULTS
The results are summarized in Table 3–7 and discussed in the
following for each perspective.
The “Technology” Perspective
All the hospitals require a description of the technology
(equipment or medical device) and the purposes of the adop-
tion. Some of them (A,C) support the filling in of the proposal
through a checklist, while others (B,D) have blank forms.
While two hospitals (A,B) require the proposer to specify
the priority for the clinical department or for the hospital,
the other two hospitals (C,D) do not require this information.
Hospitals C and D collect the level of priority during the first
budget meeting when the budget committee clarifies the re-
gional priorities and the consequent hospital priorities. The
budget committees in hospitals C and D believe that this
way of acting allows them to understand what the propo-
nents think is useful, regardless the regional and hospital
priorities. All the hospitals prefer technology to be proposed
independently by the vendor. For this reason, a statement of
vendor’s reputation is not required. The information is col-
lected before the technology is adopted to benchmark the
potential vendors. Hospital D requires the statement of the
expected evolution of the technology in the next years. None
of the hospitals collects information about the existence of
alternative technologies, despite the current practice to do so.
The “Patient” Perspective
The “patient” perspective covers two areas: health-related
benefits (e.g., increase of health gains, decrease in mortal-
ity ratio, etc.) and satisfaction-related benefits (e.g., increase
in patient satisfaction, decrease in length of stay, etc.). All
the hospitals collect information about the expected clini-
cal benefits for the patients. All the proposal forms have an
open question, because of the variety of outputs or outcomes
related to the adoption of a new technology. Regarding the
health-related benefits, none of the hospitals explicitly re-
quires the benefits to be stated in terms of quality of life
or concerning the social and employment situation. A clear
statement of the ethical and psychological implications is not
required either. The same is true for satisfaction-related ben-
efits. No data are compulsory about the expected increase
or decrease of a patient’s (or his/her family’s) acceptance
or satisfaction of the new technology or the health services
that will be delivered through the adoption of the technology.
Moreover, no data are required about the impact in terms
of length of stay. These data would also be relevant for the
“Economics” perspective because of the ability to improve
efficiency. The absence of specifications regarding possible
adverse events and the required strategies to contain them is
more controversial. Only hospital D requires the benefits to
be stated in terms of safety.
The “Organization” Perspective
Three hospitals require some statements in their proposal
forms, about change management issues. Hospital A is the
only one which completely neglects this perspective. How-
ever, the other hospitals are accountable for different criteria.
Hospital C only tracks the potential impacts because of the
overlapping of the new technology with the technologies al-
ready in place. Hospitals B and D are accountable for the
expected changes in the present workflow and the implica-
tions in terms of training. It is interesting that hospital B is
accountable for changes in roles and competence and also
for implications in terms of training, whereas hospital D is
only accountable for training needs, and does not need to
track the expected changes in roles and competences. More-
over, hospital B is the only one that requires the transient
period to reach the steady-state condition and the level of
complexity expected to put the technology into routine to be
stated. Finally, none of the four hospitals collects information
about changes in cooperation between the clinic department
proposer and the other departments or the changes in coop-
eration with other hospitals, the primary care and/or the long
term care.
The “Economics” Perspective
The proposal forms have collected numerous data about the
“Economics” perspective. All the hospitals require the start-
up costs to be stated in terms of initial investment, space
and people involved. Regarding the start-up costs for people
involved, hospital D requires this need to be stated in terms of
hours a week for the different types of staff (e.g., physicians,
nurses, technicians, managers, etc.), while the others require
the number of heads of each typology. Expected revenues
and costs are analyzed, even although hospitals A and B
require the clinical departments to specify this information,
while hospitals C and D require the Financial Department to
produce the expected profit and loss accounts. The revenues
and costs analysis is limited to the hospital’s boundaries. In
fact, the statement of the expected costs for the patients or
for the National Healthcare Systems is not required. None
of the four hospitals considers the gains related to image or
reputation. It is relevant to note that none of them requires a
sensitivity analysis to understand the variance of results.
The “Level of Evidence”
The Evidence Based Medicine (EBM) approach is a pillar
on which the HTA discipline is based. The clear understand-
ing of the level of evidence associated to the sources of
information and to each contribution from literature is an
essential requirement for the decision-making process at
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Table 2. Explanation of the Criteria for the Five Perspectives (When Not Self-explanatory)
Criteria Statement of . . .
Technology Indication on which technology should be
applied
. . . indication of the proposal for patients in terms of diagnosis,
treatment, care, rehabilitation and prevention
Motivation for the proposal . . . reasons for the proposal (i.e. upgrade, substitution, new
investment etc.)
Reputation of the supplier . . . potential of danger in the transaction with the supplier as far as
for both the adoption and further maintenance of the proposal are
concerned
Indication of the upgrade . . . expected evolution of the technology and upgrade that will be
necessary
Existence of alternative technologies . . . other technologies (apart from the usual practice) that could be
used to achieve the same result
Institutions which recommend the use Self-explanatory
Priority for the department or for the
hospital
. . . to what extent the proposal fits the strategic plan of the hospital
and if it is in line with the hospital’s mission statement
Patient Clinical benefits for the patient . . . all kinds of health gains for the patient (e.g., life years gained)
Benefits on the quality of life, social or
employment situation
Self-explanatory
Potential adverse events . . . expected risks, adverse effects, or other adverse events related to
the proposal
Ethical and psychological implications . . . ethical and psychological aspects of the proposal (e.g. it should
be stated whether the proposal could affect the patient’s sense of
insecurity, discomfort or anxiety compared to the usual practice).
Patient/Family acceptance or satisfaction . . . expected acceptance by the patient or his/her family (e.g. this
criteria is relevant for proposals regarding telemedicine solutions)
Organization Changes in the workflow in terms of
pattern of activities and information
processing
Self-explanatory
Changes in roles and competence . . . staff-related aspects of the proposal, identifying which staff
groups will be affected by the implementation of the proposal in
terms of roles and competences
Implications in term of training, working
environment and management practice
Self-explanatory
Transient period to reach the steady-state
condition
Self-explanatory
Changes in cooperation between the
department of the proposer and other
departments
. . . changes that will affect other departments or service functions in
the hospital
Changes in the cooperation with other
hospitals, the primary care and the
long-term care
. . . changes that will affect cooperation with other hospitals, regions,
the primary sector etc. (e.g., in connection with changes of the
requested pathway)
Economics Start-up costs . . . any start-up costs for equipment, rebuilding, training etc.
Activities in terms of patients and case mix Self-explanatory (statement is for at least the next couple of years)
Benefits in term of reputation gain Self-explanatory
Expected revenues Self-explanatory (statement is for at least the next couple of years)
Expected running costs Self-explanatory (statement is for at least the next couple of years)
Expected costs for the NHS and the
patients
Self-explanatory (statement is for at least the next couple of years)
Variance of results and sensitivity analysis Self-explanatory
Type of adoption . . . type of contract for the adoption (e.g. purchase, leasing, service
etc.)
Evidence Efficacy or Effectiveness Self-explanatory
Patient/Family acceptance or satisfaction Self-explanatory
Performances of the technology . . . evidence about performance of the proposal in terms of
reliability, break-downs, maintenance costs etc.
Organizational changes and inertia to
change
. . . evidence about the success or failure of adoption in other
hospitals, clarifying the actions implemented to manage the inertia
to change
Cost-effectiveness or cost-benefit Self-explanatory
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Table 3. Criteria Used for the Assessment of the “Technology” Dimension









Motivation for the proposal Checklist: end of life,
substitution, new
investment





and whether it is a
substitution or new
investment
Reputation of the supplier Not explicitly
required
Not explicitly required It is recommended to
not specify the
supplier
It is recommended to
not specify the
supplier
Indication of the upgrade Not explicitly
required







































a For example, the Food & Drug Administration, the European Commission for Medical Devices, scientific associations, lobbies of patients, etc.
b NHS, National Healthcare System.
Table 4. Criteria Used for the Assessment of the “Patient” Dimension
Patient A B C D
Clinical benefits for the patient Open question Open question Open question Open question
Benefits on the quality of life,
social or employment situation
Not explicitly required Not explicitly required Not explicitly required Not explicitly required
Potential adverse events Not explicitly required Not explicitly required Not explicitly required Not explicitly required
Ethical and psychological
implications
Not explicitly required Not explicitly required Not explicitly required Not explicitly required
Patient/Family acceptance or
satisfaction
Not explicitly required Not explicitly required Not explicitly required Not explicitly required
each level in healthcare. The behavior of the four hospitals is
different concerning the EBM approach. Two hospitals (A,B)
do not require any proof of evidence about the data provided
to promote the adoption of a healthcare technology. Hospi-
tal D requires at least five citations about the effectiveness
of the technology under review, without specifying the level
of evidence required (i.e., randomized clinical trial vs. the
opinion of a panel of experts). Finally, hospital C requires
all the necessary evidence about the cost-effectiveness of the
technology under review to be provided and specifies the
existence of guidelines to use the technology in the daily
clinical practice.
DISCUSSION AND CONCLUSIONS
The review of the proposal forms for the adoption of new
technology shows that hospitals have different levels of ac-
countability concerning the data that HTA frameworks at a
hospital level claim to be relevant. Data that are not collected
in proposal forms can be collected during further meetings
by the budget committee: in view of this, further research
is required to understand the level of integration between
HTA and budgeting. In particular, the authors believe that at
least four questions should be investigated: (i) Should HTA
be multidimensional at a hospital level? (ii) Should HTA
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Table 5. Criteria Used for the Assessment of the “Organization” Dimension
Organization A B C D
Changes in the workflow in
terms of activities and
information processing
Not explicitly required Statement of changes








Changes in roles and
competence b
Not explicitly required Statement of the
groups affected by
the changes
Not explicitly required Not explicitly required









in place within the





Transient period to reach
the steady-state condition




Not explicitly required Not explicitly required
Changes in the cooperation
between the department
of the proposer and the
other departments
Not explicitly required Not explicitly required Not explicitly required Not explicitly required
Changes in the cooperation
with other hospitals, the
primary care and the
long-term care
Not explicitly required Not explicitly required Not explicitly required Not explicitly required
a FTE: Full Time Equivalent.
b This criterion aims at measuring the possible inertia to change
c For example, the possibility of accommodating the technology in the existing setting
d For example, changes in current management practices because of a technology overlapping.
be evidence-based at a hospital level? (iii) Should HTA be
accountable at a hospital level? (iv) Should HTA be at a hos-
pital level? First hand considerations about each question can
be made from the previously discussed results.
The four hospitals collect data to focus their technol-
ogy assessments on the aspects that really matter to them as
organizations. In particular, it is possible to affirm that hos-
pitals are interested in (i) whether the technology works; (ii)
what it costs; (iii) what the revenues are; (iv) what the ad-
vantages are in implementing the technology. These aspects
are broadly covered in the proposal forms in the perspectives
about “technology,” “patient,” and “economics.” However,
two considerations can be made. First, it is interesting to
note that the proposal forms have an open question about the
expected benefits for the patients, without requiring specific
criteria such as benefits on quality of life, length of stay,
potential adverse events or patient satisfaction. A first expla-
nation is that there is a variety of benefits that can be achieved
by adopting new technology. From this point of view, an open
question is the best solution. A second explanation could be
that hospitals are more interested in outputs than in other
outcomes. This is not surprising. In fact, the Italian reim-
bursement system is based on DRGs and takes into account
the outputs. Hospitals are encouraged to focus on clinical
benefits (and also on the length of stay as a driver to decrease
costs) and pay less attention to aspects such as patient satis-
faction. A second consideration deals with the heterogeneity
of the level of accountability about change management. For
example, only hospital B requires data about the transient
period to reach a routine or data about groups affected by
change. The explanation is related to the lack of skills on
project management in the budget committee. In fact, physi-
cians assess clinical issues, managers assess financial issues,
technicians assess technological issues. Generally, none of
them approaches the adoption of technology as a project that
is characterized by organizational and change management
issues. Despite these findings, the authors believe that HTA,
at a hospital level, should be multidimensional and cover the
four perspectives. Only in this way can physicians, managers
and technicians select the portfolio of new technologies that
is the best balance between different competing targets such
as cost containment and quality improvement (16).
HTA should be evidence-based at each level (6). The re-
view of the proposal forms shows that two hospitals are not
accountable concerning the level of evidence. This finding
is coherent with many contributions on physicians’ behav-
ior toward the adoption of new technology. A large number
of physicians adopt new equipment or new medical devices
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Table 6. Criteria Used for the Assessment of the “Economics” Dimension
Economics A B C D
Start-up costs a Statement of resources
















Activities in terms of
patients and case mix
Statement of the level of
activities
Statement of the level of
activities
Statement of the level of
activities
Statement of the level of
activities
Benefits in terms of
reputation gain
Not explicitly required Not explicitly required Not explicitly required Not explicitly required
Expected revenues Statement of revenues Statement of revenues Revenues are calculated
by the Financial Dept.
on the basis of the
information provided
Revenues are calculated
by the Financial Dept.
on the basis of the
information provided
Expected running costs Statement of costs Statement of costs Costs are calculated by
the Financial Dept. on
the basis of the
information provided
Costs are calculated by
the Financial Dept. on
the basis of the
information provided
Expected costs for the
NHSb and the patients
Not explicitly required Not explicitly required Not explicitly required Not explicitly required
Variance of results and
sensitivity analysis
Not explicitly required Not explicitly required Not explicitly required Not explicitly required
Type of adoptionc Not explicitly required Not explicitly required Checklist: purchase,
leasing, service, other
Not explicitly required
a e.g. costs of equipment, rebuilding, training, etc.
b NHS, National Healthcare System.
c For example, purchase, leasing, service, etc.
when they are confident that the level of effectiveness of their
practice will increase (8). Their confidence is rooted roots in
either the guidelines provided by their scientific association
or in the opinion of the first users, especially when they are
the key opinion leaders. Escarce (8) claimed that the acqui-
sition of information about the consequences of adoption
derived from the personal experience of early adopters may
influence other physicians to try the technology in their own
practice.
The accountability of budget processes is necessary to
guarantee the fairness of the decision-making process and
prevent decisions from being inappropriately influenced by
a single (influential) individual (12). Any proposal should
be assessed against similar criteria to guarantee the fairness
of the selection process. This means that each proposer is
accountable and responsible for the data he/she provides. In
fact, the data provided are also the basis to deliver feedback—
when the technology is adopted—to the proposer, showing
the variations against targets and discussing the causes of
these variations. Feedback is necessary, on one hand, to cre-
ate a reputation for the proposer in terms of fairness and
competence and, on the other, to support the organization
learning about the ability of a hospital to adopt and man-
age new technology. When the variability of results is not
adequately managed and budgets for investments are not af-
fected by reputation measures, physicians believe they are
entitled to ask more and more without being responsible
for the results (13). For example, none of the four hospitals
Table 7. Dimensions of “Evidence” Required for the Proposal
Evidence concerning . . . A B C D
Efficacy or effectiveness Not explicitly required Not explicitly required Evidence about
effectiveness
required





Not explicitly required Not explicitly required Not explicitly required Not explicitly required
Performances of the
technology





Not explicitly required Not explicitly required Not explicitly required Not explicitly required
Cost-effectiveness or
cost-benefit
Not explicitly required Not explicitly required Evidence about costs
required
Not explicitly required
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in the sample performs a systematic analysis of the results
after the adoption of a technology.
The last consideration concerns the role that HTA should
play at a hospital level. As mentioned in the introduction, in
an ideal world, HTA at a hospital level, should cover all the
domains of HTA, but this is not realistic in the real world.
The authors firmly believe that the principles of rationality,
multidimensionality and evidence that are typical of HTA at
a governmental level should also apply at a hospital level and
be considered in the budget process. However, the real world
requires that the potential barriers are understood. During
the interviews, two barriers were identified. First, there is
a shortage of resources. HTA is time consuming and a full
HTA exercise could be incoherent with the need of assessing
numerous proposals within a budgeting window (5). In this
view, a full HTA exercise is only possible for those technolo-
gies which are high-cost or high-risk. Second, it is sometimes
difficult to work in a multidisciplinary committee, while de-
cision makers at a hospital level prefer to assess a technology
according to procedures based on sequential functional ar-
eas (e.g., clinic, technical, economic). In fact, each group
of decision makers has developed its own language and this
prevents communication and collaboration (10).
This study has shed first light on the integration, at a hos-
pital level, between budgeting and HTA. Based on this review
of the proposal forms, Further research is recommended to
have a full picture. Further research questions could con-
cern: How do the proponents of a new technology fill in the
proposal forms? How do they judge the perspectives and cri-
teria? How does the budget committee act to increase the
accountability and fairness of decision making?
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